JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 21 May 2001. doi:10.1083/jcb.153.5.999
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 416K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foghsgaard, L.
Right arrow Articles by Jäättelä, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foghsgaard, L.
Right arrow Articles by Jäättelä, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2001/5/999/ $5.00
The Journal of Cell Biology, Volume 153, Number 5, May 28, 2001 999-1010


Original Article

Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor

Lasse Foghsgaarda, Dorte Wissinga, Daniel Mauchb, Ulrik Lademanna, Lone Bastholmc, Marianne Boesd, Folmer Ellingc, Marcel Leistb,e, and Marja Jäätteläa
a Apoptosis Laboratory, Danish Cancer Society, Copenhagen, Denmark
b Department of Molecular Toxicology, University of Konstanz, Konstanz, Germany
c Institute of Molecular Pathology, University of Copenhagen, Copenhagen, Denmark
d Department of Pathology, Harvard Medical School, Boston, Massachusetts
e H. Lundbeck A/S, Valby, Denmark

Correspondence to: Marja Jäättelä, Apoptosis Laboratory, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. Tel:45-35257318 Fax:45-35257721 E-mail:mhj{at}biobase.dk.

Death receptors can trigger cell demise dependent or independent of caspases. In WEHI-S fibrosarcoma cells, tumor necrosis factor (TNF) induced an increase in cytosolic cathepsin B activity followed by death with apoptotic features. Surprisingly, this process was enhanced by low, but effectively inhibiting, concentrations of pan-caspase inhibitors. Contrary to caspase inhibitors, a panel of pharmacological cathepsin B inhibitors, the endogenous cathepsin inhibitor cystatin A as well as antisense-mediated depletion of cathepsin B rescued WEHI-S cells from apoptosis triggered by TNF or TNF-related apoptosis-inducing ligand. Thus, cathepsin B can take over the role of the dominant execution protease in death receptor-induced apoptosis. The conservation of this alternative execution pathway was further examined in other tumor cell lines. Here, cathepsin B acted as an essential downstream mediator of TNF-triggered and caspase-initiated apoptosis cascade, whereas apoptosis of primary cells was only minimally dependent on cathepsin B. These data imply that cathepsin B, which is commonly overexpressed in human primary tumors, may have two opposing roles in malignancy, reducing it by its proapoptotic features and enhancing it by its known facilitation of invasion.

Key Words: apoptosis, cancer, caspase independent, cathepsins, tumor necrosis factor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents